Clinical Trial Update: E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating e-cigarettes for harm reduction in smokers with opioid use disorder; recruitment is ongoing. The study investigates whether va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Tobacco Use Disorder

Drugs mentioned

• E-cigarettes (vaping products)

Snippet

Sponsor: NYU Langone Health | Conditions: Opioid Use Disorder, Cigarette Smoking | Phase 2 | Status: RECRUITING